Aspen Aerogels Inc (NYSE: ASPN) has a higher price-to-earnings ratio of 1457.48x compared to its average ratio, The 36-month beta value for ASPN is at 2.20. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 1 rating it as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for ASPN is 79.99M, and currently, shorts hold a 10.65% of that float. The average trading volume for ASPN on November 06, 2024 was 2.28M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ASPN) stock’s latest price update
The stock price of Aspen Aerogels Inc (NYSE: ASPN) has jumped by 1.42 compared to previous close of 18.25. Despite this, the company has seen a gain of 1.54% in its stock price over the last five trading days. zacks.com reported 2024-10-30 that Aspen Aerogels (ASPN) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ASPN’s Market Performance
Aspen Aerogels Inc (ASPN) has experienced a 1.54% rise in stock performance for the past week, with a -25.69% drop in the past month, and a 0.05% rise in the past quarter. The volatility ratio for the week is 4.70%, and the volatility levels for the past 30 days are at 6.99% for ASPN. The simple moving average for the last 20 days is -9.93% for ASPN’s stock, with a simple moving average of -14.87% for the last 200 days.
Analysts’ Opinion of ASPN
Many brokerage firms have already submitted their reports for ASPN stocks, with Barclays repeating the rating for ASPN by listing it as a “Overweight.” The predicted price for ASPN in the upcoming period, according to Barclays is $27 based on the research report published on August 06, 2024 of the current year 2024.
ROTH MKM, on the other hand, stated in their research note that they expect to see ASPN reach a price target of $22. The rating they have provided for ASPN stocks is “Buy” according to the report published on March 06th, 2024.
The Benchmark Company gave a rating of “Buy” to ASPN, setting the target price at $14 in the report published on March 20th of the previous year.
ASPN Trading at -22.37% from the 50-Day Moving Average
After a stumble in the market that brought ASPN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -44.16% of loss for the given period.
Volatility was left at 6.99%, however, over the last 30 days, the volatility rate increased by 4.70%, as shares sank -17.37% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -38.83% lower at present.
During the last 5 trading sessions, ASPN rose by +1.54%, which changed the moving average for the period of 200-days by +51.60% in comparison to the 20-day moving average, which settled at $20.55. In addition, Aspen Aerogels Inc saw 17.30% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ASPN starting from Young Donald R, who sale 63,355 shares at the price of $30.03 back on Sep 30 ’24. After this action, Young Donald R now owns 483,640 shares of Aspen Aerogels Inc, valued at $1,902,551 using the latest closing price.
Donald R. Young, the President, CEO, Director of Aspen Aerogels Inc, proposed sale 134,629 shares at $27.62 during a trade that took place back on Sep 30 ’24, which means that Donald R. Young is holding shares at $3,718,452 based on the most recent closing price.
Stock Fundamentals for ASPN
Current profitability levels for the company are sitting at:
- 0.33 for the present operating margin
- 0.56 for the gross margin
The net margin for Aspen Aerogels Inc stands at 0.0. The total capital return value is set at 0.21. Equity return is now at value 0.30, with 0.20 for asset returns.
Based on Aspen Aerogels Inc (ASPN), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at -0.17. The debt to equity ratio resting at 0.24. The interest coverage ratio of the stock is 14.64.
Currently, EBITDA for the company is -31.03 million with net debt to EBITDA at 0.44. When we switch over and look at the enterprise to sales, we see a ratio of 3.79. The receivables turnover for the company is 3.54for trailing twelve months and the total asset turnover is 0.55. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.46.
Conclusion
In conclusion, Aspen Aerogels Inc (ASPN) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
